Loading clinical trials...
Loading clinical trials...
Use of Hyperpolarized 129 Xe MR Lung Imaging in Children and Adults
The goal of this study is to evaluate the usefulness of hyperpolarized (HP) 129Xe (xenon) gas MRI for regional assessment of lung function in a normal population of children and adults and in adults and also in children with respiratory compromise due to a variety of diseases.
Hyperpolarized 129Xe will be produced, by trained staff, using a polarizer housed at Cincinnati Children's Hospital Medical Center. Individual imaging sessions will be done on a single day and will involve administration of (maximum) 1 liter doses (less for children) for up to four MRI scans. Subject will inhale hyperpolarized xenon gas and hold breath for up to 16 seconds during the MRI scans. In addition to 129 Xe MRI, a series of anatomical conventional proton MR images may also be collected. Follow up phone calls will be done one day and 30 days from the MRI date.
Age
6 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
December 1, 2014
Primary Completion Date
December 31, 2028
Completion Date
August 31, 2029
Last Updated
February 17, 2026
300
ESTIMATED participants
Hyperpolarized 129 Xenon
DRUG
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
NCT03281876
NCT01360398
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01657526